SEGUFIX-BANDAGEN DAS HUMANE SYSTEM GMBH & CO. KG – Trademark Portfolio

Entity Type: 13

SEGUFIX-BANDAGEN DAS HUMANE SYSTEM GMBH & CO. KG holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SEGUFIX. The owner is based in D-21266 JESTEBURG.

ALLERBEEKSRING 33

D-21266 JESTEBURG , DE

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SEGUFIX
SEGUFIX
Registered 1976

Trademark Classifications

SEGUFIX-BANDAGEN DAS HUMANE SYSTEM GMBH & CO. KG's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SEGUFIX-BANDAGEN DAS HUMANE SYSTEM GMBH & CO. KG have?

SEGUFIX-BANDAGEN DAS HUMANE SYSTEM GMBH & CO. KG has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SEGUFIX-BANDAGEN DAS HUMANE SYSTEM GMBH & CO. KG file in?

SEGUFIX-BANDAGEN DAS HUMANE SYSTEM GMBH & CO. KG files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SEGUFIX-BANDAGEN DAS HUMANE SYSTEM GMBH & CO. KG's most well-known trademarks?

SEGUFIX-BANDAGEN DAS HUMANE SYSTEM GMBH & CO. KG's registered trademark portfolio includes well-known marks such as SEGUFIX. These are among 1 currently registered trademark in the portfolio.

What is SEGUFIX-BANDAGEN DAS HUMANE SYSTEM GMBH & CO. KG's trademark registration success rate?

SEGUFIX-BANDAGEN DAS HUMANE SYSTEM GMBH & CO. KG has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.